Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P5TG
|
||||
Former ID |
DIB011819
|
||||
Drug Name |
Multi-epitope peptide melanoma vaccine
|
||||
Synonyms |
Multi-epitope peptide melanoma vaccine (MART-1, gp100, tyrosinase); Multi-epitope peptide melanoma vaccine (MART-1, gp100, tyrosinase), University of Pittsburgh; MART-1 (51-73) + MART-1(27-35); MART-1(NSC-672643), gp100(NSC-683472), tyrosinase (NSC-699048); MGT (MART-1 (27-35), gp100(209-217, 210M), tyrosinase (368-376, 370D)); (MART-1, gp100, tyrosinase) + (IFNalfa2b + GM-CSF); (MART-1, gp100, tyrosinase) + GM-CSF; (MART-1, gp100, tyrosinase) + IFNalfa2b
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 3 | [521514] | ||
Company |
University of Pittsburgh
|
||||
Target and Pathway | |||||
Target(s) | MART-1 melanoma antigen | Target Info | [544270] | ||
Melanocytes lineage-specific antigen GP100 | Target Info | [544270] | |||
Tyrosine oxidase | Target Info | [544270] | |||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.